Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease
Did you know that immunoglobulin A nephropathy has very recently seen 2 treatments first licensed for its management?
Credit available for this activity expires: 6/29/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993766?ecd=bdc_podcast_libsyn_mscpedu
Create your
podcast in
minutes
It is Free